Français
ItalianoBond Abbot 2.9% ( US002824BD12 ) in USD
| Issuer | Abbot |
| Market price | 100.455 % ⇌ |
| Country |  United States
|
| ISIN code |
 US002824BD12 ( in USD )
|
| Interest rate | 2.9% per year ( payment 2 times a year) |
| Maturity | 30/11/2021 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 850 000 000 USD |
| Cusip | 002824BD1 |
| Detailed description |
Abbott Laboratories is a global healthcare company that develops, manufactures, and sells a broad range of healthcare products, including medical devices, nutritionals, and pharmaceuticals. An analysis of a notable fixed-income instrument, specifically an obligation issued by Abbott, a globally recognized diversified healthcare company focused on diagnostic, medical device, nutritional, and pharmaceutical products, highlights key details of its US002824BD12 bond. This particular security, bearing the CUSIP code 002824BD1 and denominated in USD, originated from the United States, showcasing a 2.9% interest rate with semi-annual payment frequency. The bond represented a significant financial undertaking, with a total issuance size amounting to $2,850,000,000, and was accessible to investors with a minimum purchase size of $2,000. While its market performance reflected a price of 100.455% during its active trading period, it is imperative to note that this instrument reached its maturity date on November 30, 2021, and has since been fully redeemed and repaid to its bondholders, concluding its lifecycle within the fixed-income market. |